Search

everythinglearnresearchcommunity

for

Search:↓

Protein analysis shows aging changes in scalp cell types from women.

Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Human-induced stem cell-created skin models can help understand skin diseases by studying the skin's layers.

Skin aging and cancer development are influenced by the competition between stem cells.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

Long COVID affects many body systems and needs careful management.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Many COVID-19 survivors, especially women, experience hair loss and skin color changes, needing specific post-recovery care.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Sex hormones may affect COVID-19 severity and outcomes.

COVID-19 can cause temporary hair loss.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

18% of COVID-19 survivors experience PTSD, with risk factors including age, gender, smoking, and lung damage.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 can cause skin problems.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Better understanding and new treatments for hidradenitis suppurativa are emerging, but more research is needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Cold Plasma shows promise for healing wounds by killing bacteria and helping tissue grow.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.